Both in Pharmaceuticals
MAIA Biotechnology vs Acrivon Therapeutics
Over the past year MAIA returned −6.9% and ACRV returned −28.3%; their daily moves had a correlation of 0.15.
MAIA −6.9% ACRV −28.3%Growth of $1, one year, split-adjusted
| Metric | MAIA | ACRV |
|---|---|---|
| Price | $1.08 | $1.67 |
| Market cap | $66.7M | $71.6M |
| Today | −1.82% | +3.73% |
| 1 month | −8.5% | −15.7% |
| 6 months | −22.3% | −19.7% |
| Year to date | −29.4% | −30.7% |
| 1 year | −12.9% | −16.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $27.6M | $90.0M |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 70.6% |
| Short % of float | 6.0% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).